- This event has passed.
An evening with Marc Koska OBE and Philip Leslie
23 November 2023 @ 6:00 pm - 8:00 pm AWST
Join the WA Life Sciences Innovation Hub for an evening of conversation with Marc Koska OBE and Philip Leslie (ApiJect).
Join the WA Life Sciences Innovation Hub for an evening of conversation with Marc Koska OBE and Philip Leslie about developing innovative drug delivery devices for the global healthcare market and the ApiJect story. Refreshments and networking to follow.
Every year, more than 1 million people are killed due to syringe reuse and unsafe injection practices in healthcare facilities.
In the 1980’s, Marc’s innovative auto-disable syringe prevented the spread of disease and infection, helping save more than 12 million lives. Marc is now co-founder and Head of R&D of ApiJect Systems, a company developing an innovative new drug delivery platform with the potential to enable more liquid medicines and vaccines to safely reach more patients across the world.
Marc is joined by ApiJect’s Senior Advisor, Manufacturing Philip Leslie, whose exceptional service of more than 30 years’ pharmaceutical manufacturing experience has seen him inducted into Victoria’s Manufacturing Hall of Fame in 2017.
Agenda
6:00pm Registration
6:15pm Presentation
6:30pm Fireside chat with Marc and Philip moderated by Tracey Wilkinson
7:15pm Networking
8:00pm Event close
About ApiJect
In the mid-1980s, Mr Marc Koska invented the revolutionary K-1 auto-disable syringe, which prevented the spread of bloodborne diseases and infection by making the syringe impossible to reuse. It is believed his invention has helped to save more than 12 million lives. Watch his 2009 TED Talk here.
In 2005, he founded the nonprofit SafePoint Trust to educate children in developing nations about the dangers of employing used needles. Among many other honors bestowed upon Marc, he was made an Officer of the Order of the British Empire for his “contribution to global healthcare.”
In 2015, Marc founded ApiJect Ltd and invented a breakthrough Blow-Fill-Seal (BFS) injection device. The Prefilled ApiJect Injector is designed for simplicity: just prior to injection, a fill-finished Blow-Fill-Seal container and intramuscular needle hub are push-twisted together by a healthcare professional.
This new drug delivery platform has the potential to enable more liquid medicines and vaccines to safely reach more patients across the world.
Today, ApiJect Systems is a medical technology company working to improve how sterile liquid medicines and vaccines are fill-finished across the world.
If you have any questions, contact Rebekah Crags at rebekah.craggs@mtpconnect.org.au